News

Beware Of Fake Oxycontin In Circulation, NAFDAC Warns Public

Published

3 months ago

March 21, 2025

The National Agency for Food and Drug Administration and Control has alerted the public on falsified Oxycontin 80mg (oxycodone hydrochloride) which it says was detected in an unregulated market in Switzerland.

The public alert with No. 07/2025 was uploaded on the agency’s website on Thursday.
The agency said the issue about falsified medicine was reported to the World Health Organisation by the genuine manufacturer, MUNDIPHARMA, in February.

It said the falsified product imitated the genuine OXYCONTIN 80mg authorised for sale in Poland, adding that the genuine OXYCONTIN (oxycodone hydrochloride) is a semi-synthetic opioid indicated for the treatment of moderate to severe pain.

It said laboratory tests of samples for the falsified product were conducted by the Drug Information Centre in Zurich, Switzerland, and that WHO, DIZ’s drug-checking service determined that the tablets did not contain oxycodone but a synthetic opioid likely to be a nitazene compound.

According to NAFDAC, Nitazene derivatives (e.g., metonitazene, isotonitazene, fluonitazene) are potent synthetic opioids, primarily used in research due to their high addiction potential and severe side effects.

It said these substances could be hundreds of times stronger than oxycodone, posing a high overdose risk, stressing that limited information is available on their risks, toxicity, side effects, and long-term consequences.

“The identified product in this alert is confirmed as falsified on the basis that it deliberately/fraudulently misrepresented its identity, composition, or source.

“The falsified product imitates OXYCONTIN 80mg manufactured and marketed by MUNDIPHARMA in the Polish market. MUNDIPHARMA has confirmed that the product was falsified and was not produced by their company.

“This falsified product has been found to contain undeclared nitazene compounds, which pose a significant risk due to the high likelihood of adverse events, even in small doses. Nitazenes produce similar effects to other opioids.

“Their high potency carries a high risk of overdose and death. Using nitazene derivatives has been linked to several deaths.

“Mixing them with other depressants like alcohol or benzodiazepines can be very dangerous, leading to severe effects like respiratory depression, low blood pressure, coma, or even death,” NAFDAC said.

It said that this falsified product posed a particular risk to individuals with substance use disorders who might perceive this falsified product as a safe and quality-assured medicine.

NAFDAC said that visible discrepancies were observed on the falsified product such as the placement of the batch and expiry dates on the counterfeit product were incorrect.

It added that the falsified product batch and expiry date are visible on the front side of the blister strip, adding that genuine OXYCONTIN has the batch and expiry date visible on the back of the blister strip.

NAFDAC stated that on the falsified product, the expiry date is on the left and the batch number is on the right, pointing out that genuine OXYCONTIN has the batch number on the left and the expiry date on the right.

According to NAFDAC, all its zonal directors and state coordinators have been instructed to conduct surveillance and retrieve any falsified products of this medicine found within their zones and states in Nigeria.

It said that importers, distributors, retailers, healthcare professionals, and consumers are hereby advised to exercise caution and vigilance within the supply chain to avoid importation, distribution, sale, and use of falsified OXYCONTIN tablets.

NAFDAC said that all medical products/ medical devices must be obtained from authorised/licensed suppliers, stressing that products’ authenticity and physical condition should be carefully checked.

It advised healthcare professionals and consumers to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, or call NAFDAC on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng.

It said that healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office.

NAFDAC said that healthcare professionals and patients could also report to the agency through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med- safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng

NAN

News

Lagos Suspends BRT Lane Enforcement On Eko Bridge, Odo Iya-Alaro

Published

10 hours ago

July 2, 2025

Editor

The Lagos State Government has temporarily suspended enforcement of the Bus Rapid Transit lane along the Eko Bridge and Odo Iya-Alaro corridor to ease growing traffic congestion.

This gridlock is a result of the ongoing structural rehabilitation on the Ogudu-Ifako Bridge expansion joint.

Special Adviser to the Lagos Governor on Transportation, Sola Giwa announced the suspension on Wednesday, describing it as a strategic move to tackle gridlock in affected parts of the city.

“This remedial measure, conceived as a palliative response to mitigate commuter hardship, aligns with the Lagos State Government’s forward-thinking and adaptive transportation strategy under the THEMES Plus Agenda of Governor Babajide Sanwo-Olu, particularly within the framework of sustainable traffic management and infrastructure modernisation,” Giwa said.

He explained that the temporary suspension is a transitional and conditional measure aimed at absorbing the anticipated vehicular overflow caused by the partial closure of the Ifako-bound carriageway of the Third Mainland corridor.

“We are fully cognizant of the immense strain currently imposed on key ingress routes into the Lagos Mainland. Consequently, this tactical suspension of BRT lane enforcement is a calculated response designed to deliver immediate relief, reduce commuting time, and preserve the fluidity of vehicular movement throughout the duration of the bridge repairs,” he added.

According to him, the directive takes immediate effect and allows general vehicular access to previously restricted BRT corridors on Eko Bridge and Odo Iya-Alaro, particularly during peak travel periods.

He said this move is expected to expand available road capacity and ease traffic along critical routes.

Giwa, however, stressed that commercial buses and articulated vehicles must remain in compliance with existing safety rules and loading guidelines to avoid worsening traffic conditions or compromising public safety.

He also disclosed that the Lagos State Traffic Management Authority has been mobilised to strengthen its presence along the affected corridors.

“Enhanced personnel deployment and traffic equipment are now in place to ensure orderly conduct, prevent exploitation of the temporary suspension, and respond promptly to any emergent traffic disturbances,” Giwa stated.

News

Lagos Opens Teacher Recruitment Portal For Two Weeks

Published

10 hours ago

July 2, 2025

Editor

The Lagos State Government has announced the reactivation of its teaching job recruitment portal to allow qualified individuals to apply for entry-level teaching positions.

In a notice issued by the Lagos State Teaching Service Commission on Tuesday, the portal will be open for applications from Tuesday, July 1 to Monday, July 14, 2025.

“The Lagos State Teaching Service Commission is set to reactivate its Recruitment Portal as a bold step towards improving access to employment opportunities, equity, and fairness.

“The job portal, which will be accessible for two weeks (Tuesday, July 1st 2025, to Monday, July 14th, 2025), is intended to provide a centralised platform where individuals can apply for State Teaching jobs at the entry level (GL 08) in their relevant fields,” the notice read.

The move, according to the Commission, is aimed at improving access to employment opportunities in the education sector while ensuring equity and fairness.

TESCOM urged interested applicants with a degree in Education or other relevant qualifications to visit the official portal https://tescomjobs.lagosstate.gov.ng and apply for teaching roles at Grade Level 08.

The notice was signed by the Chairman of the Lagos State Teaching Service Commission.

News

FG Unveils N50m Grant To Boost Student Innovation, Entrepreneurship

Published

11 hours ago

July 2, 2025

Editor

The Minister of Education, Dr. Tunji Alausa, has announced a N50m Student Grant Venture Capital Initiative to support scaling student-led enterprises in Nigeria’s tertiary institutions.

Alausa said the initiative aims to bridge the gap between academia and industry by turning homegrown research into commercially viable products and services.

The minister made the announcement on Wednesday in Abuja when he inaugurated the Research and Innovation Commercialisation Committee.

He said the scheme, which will be anchored by TETFund in partnership with the Bank of India, targets undergraduate students in 300-level and above with viable business models and innovations ready for market expansion.

According to the minister, the development is aligned with President Bola Tinubu’s agenda of transitioning Nigeria from a resource-based economy to a knowledge-driven one.

“We have hundreds of thousands of young geniuses across our institutions. This fund is designed to unlock their potential and help them build globally competitive enterprises,” the minister said.

On her part, the Minister of State for Education, Prof. Suwaiba Ahmad, described the inauguration as a landmark moment in Nigeria’s education and innovation history.

“For too long, research in our tertiary institutions has been reduced to tools for promotion rather than solutions for development. This must change,” she said.

In his response, the Committee Chairman, Dr. Tayo Aduloju, described the RICC as “a matter of national urgency”, noting that Nigeria’s research investment as a percentage of GDP is among the lowest when compared to peer nations.